Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Blood Research|January 30, 2026
The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemiaSuresh Prajapati, Charmi Jyotishi, Mansi Patel, et al.Genetic Testing and Molecular Biomarkers|April 17, 2026
Circulating Alu Elements as Biomarkers for Radiation-Induced Toxicity in CancerMansi Patel, Charmi Jyotishi, Suresh Prajapati, et al.Clinical and Experimental Immunology|February 9, 2026
LncRNAs at the Frontline of Neuroimmune Crosstalk in Oral CancerMansi Patel, Charmi Jyotishi, Suresh Prajapati, et al.Annals of Hematology|November 7, 2025
Phytochemicals in overcoming venetoclax resistance in acute myeloid leukemia: mechanistic insights and therapeutic potentialSuresh Prajapati, Mansi Patel, Charmi Jyotishi, et al.Reviews on Recent Clinical Trials|June 27, 2025
Assessing the Efficacy of Small Molecule Drugs in Hutchinson-Gilford Progeria Syndrome: A Review of Clinical TrialsDrishti Desai, Charmi Jyotishi, Suresh Prajapati, et al.Asian Pacific Journal of Cancer Prevention : APJCP|May 22, 2026
Selective Inhibition of VEGFR2 in Preference to Other Receptor Tyrosine Kinases by Diosgenin, a Natural Steroidal SapogeninCharmi Jyotishi, Mansi Patel, Suresh Prajapati, et al.Journal of Liver Cancer|December 16, 2025
Exploring Single-Cell and Multi-Omics Technologies and Their Role in Unravelling Tumor Heterogeneity of Hepatocellular CarcinomaCharmi Jyotishi, Suresh Prajapati, Mansi Patel, et al.Discover Oncology|January 16, 2026
Therapeutic potential of diosgenin in hepatocellular carcinoma through molecular mechanisms and nanodelivery strategiesCharmi Jyotishi, Mansi Patel, Suresh Prajapati, et al.Genomics & Informatics|October 28, 2025
In silico design of a multi-epitope pan vaccine targeting Schistosoma speciesDaksh Gandvi, Charmi Jyotishi, Mansi Patel, et al.Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2025
Screening of Oncogenic Proteins and Development of a Multiepitope Peptide Vaccine Targeting AKT1 and PARP1 for Breast Cancer by Integrating Reverse Vaccinology and Immune-Informatics ApproachesSakshi Gupta, Drashti Desai, Mansi Patel, et al.Pageof 1